Literature DB >> 22882267

Are differentially expressed microRNAs useful in the diagnostics of malignant pleural mesothelioma?

Morten Andersen, Morten Grauslund, Marwa Muhammad-Ali, Jesper Ravn, Jens Benn Sørensen, Claus B Andersen, Eric Santoni-Rugiu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22882267     DOI： 10.1111/j.1600-0463.2012.02891.x

Source DB:  PubMed          Journal:  APMIS        ISSN： 0903-4641            Impact factor:   3.205


× No keyword cloud information.
  7 in total

Review 1.  Role of microRNAs in malignant mesothelioma.

Authors:  A Truini; S Coco; A Alama; C Genova; C Sini; M G Dal Bello; G Barletta; E Rijavec; G Burrafato; F Boccardo; F Grossi
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

Review 2.  MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets.

Authors:  Glen Reid
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

3.  Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component.

Authors:  Shinji Matsumoto; Kazuki Nabeshima; Makoto Hamasaki; Tatsuki Shibuta; Tsukuru Umemura
Journal:  Med Oncol       Date:  2014-10-31       Impact factor: 3.064

Review 4.  Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.

Authors:  Luigina Micolucci; Most Mauluda Akhtar; Fabiola Olivieri; Maria Rita Rippo; Antonio Domenico Procopio
Journal:  Oncotarget       Date:  2016-09-06

5.  MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study.

Authors:  Paola Mozzoni; Luca Ampollini; Matteo Goldoni; Rossella Alinovi; Marcello Tiseo; Letizia Gnetti; Paolo Carbognani; Michele Rusca; Antonio Mutti; Antonio Percesepe; Massimo Corradi
Journal:  Dis Markers       Date:  2017-07-03       Impact factor: 3.434

6.  Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma.

Authors:  Daniel G Weber; Katarzyna Gawrych; Swaantje Casjens; Alexander Brik; Martin Lehnert; Dirk Taeger; Beate Pesch; Jens Kollmeier; Torsten T Bauer; Georg Johnen; Thomas Brüning
Journal:  Dis Markers       Date:  2017-02-21       Impact factor: 3.434

7.  Correlation of MET-Receptor Overexpression with MET Gene Amplification and Patient Outcome in Malignant Mesothelioma.

Authors:  Eric Santoni-Rugiu; Maya Jeje Schuang Lü; Jan Nyrop Jakobsen; Linea Cecilie Melchior; Jesper Ravn; Jens Benn Sørensen
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.